These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7659198

  • 1. EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease.
    Valladares-Neto DC, Buchsbaum MS, Evans WJ, Nguyen D, Nguyen P, Siegel BV, Stanley J, Starr A, Guich S, Rice D.
    Neuropsychobiology; 1995; 31(4):173-81. PubMed ID: 7659198
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 3. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE.
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [Abstract] [Full Text] [Related]

  • 4. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
    Koss E, Friedland RP, Ober BA, Jagust WJ.
    Am J Psychiatry; 1985 May; 142(5):638-40. PubMed ID: 3872604
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Preliminary studies.
    Buchsbaum MS, Kesslak JP, Lynch G, Chui H, Wu J, Sicotte N, Hazlett E, Teng E, Cotman CW.
    Arch Gen Psychiatry; 1991 Sep; 48(9):840-7. PubMed ID: 1929775
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE.
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [Abstract] [Full Text] [Related]

  • 10. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL, Kamo H, Harrop R, Li DK, Tuokko H, McGeer EG, Adam MJ, Ammann W, Beattie BL, Calne DB.
    CMAJ; 1986 Mar 15; 134(6):597-607. PubMed ID: 3512063
    [Abstract] [Full Text] [Related]

  • 11. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
    Cutler NR.
    Prog Neuropsychopharmacol Biol Psychiatry; 1986 Mar 15; 10(3-5):309-21. PubMed ID: 2948218
    [Abstract] [Full Text] [Related]

  • 12. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
    Koppel J, Sunday S, Goldberg TE, Davies P, Christen E, Greenwald BS, Alzheimer's Disease Neuroimaging Initiative.
    Am J Geriatr Psychiatry; 2014 Jul 15; 22(7):698-707. PubMed ID: 23672944
    [Abstract] [Full Text] [Related]

  • 13. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
    Fukuyama H, Harada K, Yamauchi H, Miyoshi T, Yamaguchi S, Kimura J, Kameyama M, Senda M, Yonekura Y, Konishi J.
    J Neurol Sci; 1991 Dec 15; 106(2):128-34. PubMed ID: 1802960
    [Abstract] [Full Text] [Related]

  • 14. Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia.
    Szelies B, Mielke R, Herholz K, Heiss WD.
    Electroencephalogr Clin Neurophysiol; 1994 Aug 15; 91(2):131-9. PubMed ID: 7519142
    [Abstract] [Full Text] [Related]

  • 15. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
    Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, Mori E.
    J Nucl Med; 1997 Jun 15; 38(6):925-8. PubMed ID: 9189143
    [Abstract] [Full Text] [Related]

  • 16. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P, Dani A, Furey ML, Alexander GE, Freo U, Grady CL, Mentis MJ, Mangot D, Simon EW, Horwitz B, Haxby JV, Schapiro MB.
    Am J Psychiatry; 1997 Aug 15; 154(8):1063-9. PubMed ID: 9247390
    [Abstract] [Full Text] [Related]

  • 17. P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism.
    Szelies B, Mielke R, Grond M, Heiss WD.
    J Neurol Sci; 1995 May 15; 130(1):77-81. PubMed ID: 7650534
    [Abstract] [Full Text] [Related]

  • 18. Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults.
    Gardener SL, Sohrabi HR, Shen KK, Rainey-Smith SR, Weinborn M, Bates KA, Shah T, Foster JK, Lenzo N, Salvado O, Laske C, Laws SM, Taddei K, Verdile G, Martins RN.
    J Alzheimers Dis; 2016 Mar 31; 52(2):661-72. PubMed ID: 27031482
    [Abstract] [Full Text] [Related]

  • 19. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.
    Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH, Derenzo SE.
    J Comput Assist Tomogr; 1983 Aug 31; 7(4):590-8. PubMed ID: 6602819
    [Abstract] [Full Text] [Related]

  • 20. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
    Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE.
    J Nucl Med; 1995 Jul 31; 36(7):1238-48. PubMed ID: 7790950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.